Gadolinium chelates for magnetic resonance imaging
AssigneeSchering Corporation
InventorsHeinz Gries, Douwe Rosenberg, Hanns-Joachim Weinmann, Ulrich Speck, Wolfgang Mutzel, Georg-Alexander Hoyer, Heinrich Pfeiffer, deceased, Franz-Josef Renneke
Life of this patent
Estimating the term…
Abstract
A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more Gadolinium ions and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
Claims10
The di-N-methylglucamine salt of the gadolinium (III) complex of diethylene-triaminepentaacetic acid.
The di-N-methylglucamine salt of the gadolinium(III) chelate complex of diethylenetriaminepentaacetic acid in sterile form.
Isolated di-N-methylglucamine salt of the gadolinium(III) chelate complex of diethylenetriaminepentaacetic acid.
A chelate complex of gadolinium(III) or a salt thereof, wherein said chelate complex or salt is in sterile form and said gadolinium does not emit ionizing radiation.
A chelate complex of gadolinium(III) or a salt thereof, wherein said chelate complex or salt is in sterile form and said gadolinium is not a radionuclide.
A chelate complex of gadolinium(III) or a salt thereof, wherein said chelate complex or salt is in sterile form and said chelate complex or salt is not radioactive.
Dependencies are inferred from the claim text.